Viewing StudyNCT00243035



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00243035
Status: TERMINATED
Last Update Posted: 2013-10-08
First Post: 2005-10-20

Brief Title: Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: NCI-2012-02675
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators